$3.32+0.64 (+23.88%)
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada.
AirSculpt Technologies, Inc. in the Healthcare sector is trading at $3.32. The stock is currently near its 52-week low of $1.51, remaining 28.4% below its 200-day moving average. Technical signals show neutral RSI of 65 and bullish MACD crossover, explaining why AIRS maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a ...
Despite a decline in revenue, AirSculpt Technologies Inc (AIRS) focuses on new services and strategic marketing to drive future growth.
Moby summary of AirSculpt Technologies, Inc.'s Q4 2025 earnings call
AirSculpt Technologies (NASDAQ:AIRS) reported fourth-quarter and full-year 2025 results while outlining initiatives management said have stabilized the business and returned same-store sales to growth entering fiscal 2026. On the company’s earnings call, Chief Executive Officer Yogi Jashnani said sa
AirSculpt Technologies (AIRS) is back in focus after a large insider share purchase, a brief delay to its annual report filing for technical accounting work, and fresh preliminary 2025 revenue and guidance headlines. See our latest analysis for AirSculpt Technologies. At a share price of $2.69, AirSculpt has a 7 day share price return of 40.1% and a 30 day share price return of 42.33%. However, the 3 year total shareholder return of a 45.33% decline shows longer term investors have had a very...
AirSculpt Technologies, Inc. has recently updated its outlook, guiding first-quarter 2026 revenue to US$38.5–US$39.5 million while confirming that same-store revenue is expected to be approximately flat at the midpoint. The company also reported preliminary figures showing fourth-quarter 2025 revenue of US$33.4 million with a roughly 16% same-store revenue decline, but indicated that same-store performance had improved to a single-digit decline by December 2025. We’ll now examine how this...